Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Johanna Lager"'
Autor:
Martin Ebinger, Hans-Georg Rammensee, Juliane S Walz, Ana Marcu, Andreas Schlosser, Torsten Pietsch, Martin Schuhmann, Anne Keupp, Nico Trautwein, Pascal Johann, Matthias Wölfl, Johanna Lager, Camelia Maria Monoranu, Lisa M Henkel, Ulrich Wilhelm Thomale, Erdwine Klinker, Paul G Schlegel, Florian Oyen, Yair Reisner, Matthias Eyrich
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/d14d72c4908244119a50f49fe17e6beb
Autor:
E. Klinker, Yair Reisner, Florian Oyen, Ana Marcu, Camelia-Maria Monoranu, Matthias Wölfl, Johanna Lager, Nico Trautwein, Lisa M. Henkel, J. Krauss, Anne Keupp, Pascal Johann, Andreas Schlosser, Martin Ebinger, Martin U. Schuhmann, Thorsten Pietsch, Juliane S. Walz, Paul-Gerhardt Schlegel, Hans-Georg Rammensee, Ulrich-W. Thomale, Matthias Eyrich
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundAtypical teratoid/rhabdoid tumors (AT/RT) are highly aggressive CNS tumors of infancy and early childhood. Hallmark is the surprisingly simple genome with inactivating mutations or deletions in the SMARCB1 gene as the oncogenic driver. Neve
Autor:
Lisa M. Henkel, Ulrich-W. Thomale, Nico Trautwein, H.-G. Rammensee, Matthias Wölfl, Johanna Lager, Matthias Eyrich, Martin U. Schuhmann, Ana Marcu, Michael C. Frühwald, Paul-Gerhardt Schlegel, Antje Technau, Stefan Stevanovic, Jürgen Kraus, Martin Ebinger, Thorsten Pietsch, Pascal-David Johann, Florian Oyen, Camelia-Maria Monoranu, Yair Reisner
Publikováno v:
ResearcherID
Autor:
Stefan Stevanovic, Ana Marcu, Camelia-Maria Monoranu, Paul G. Schlegel, Nico Trautwein, Antje Technau, Yair Reisner, Ulrich W. Thomale, Florian Oyen, Matthias Eyrich, Matthias Wölfl, Johanna Lager, Pascal Johann, Torsten Pietsch, Lisa M. Henkel, Hans-Georg Rammensee, Jürgen Kraus, Martin U. Schuhmann, Michael C. Frühwald, Martin Ebinger
Atypical teratoid/rhabdoid tumors (AT/RTs) are commonly regarded as immunologically cold tumors, as they rank among malignancies with the lowest mutational load. However, low mutational burden is not necessarily correlated with poor immunogenicity, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::265c442b5125d1d9093bcedee4e627d3
https://europepmc.org/articles/PMC6012858/
https://europepmc.org/articles/PMC6012858/